These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Scheld WM; Rocha H; Sande MA; Bryan JP Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518 [TBL] [Abstract][Full Text] [Related]
7. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections. Simmons BP; Gelfand MS; Grogan J; Craft B Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031 [TBL] [Abstract][Full Text] [Related]
8. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection]. Nauciel C; Martin E Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900 [TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study. Leu HS; Lasserre R Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852 [TBL] [Abstract][Full Text] [Related]
10. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. Tuncer I; Topcu N; Durmus A; Turkdogan MK Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment for urinary tract infections in pediatric patients. Hellerstein S Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin. Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246 [TBL] [Abstract][Full Text] [Related]
14. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection]. Gao B; Hu J; Deng W Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic-therapeutic studies of ceftriaxone in premature and mature newborn infants]. Guggenbichler JP; Parth J; Frisch H Padiatr Padol; 1986; 21(1):31-6. PubMed ID: 3960561 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study of a new cephalosporin ceftriaxone (Ro 13-9904) in sepsis and other infectious forms of particular severity]. Calonghi GF; Vezzani F G Ital Chemioter; 1981; 28(1-2):55-9. PubMed ID: 6290304 [No Abstract] [Full Text] [Related]
17. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis. Kim KS Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491 [TBL] [Abstract][Full Text] [Related]
18. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia. Opal SM; Palardy JE; Parejo N; Jasman RL Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of ceftriaxone (R013-9904) in the treatment of septicemia caused by gram-negative bacilli]. Naessens A; Pierard D; Roels P; Lauwers S Pathol Biol (Paris); 1983 May; 31(5):362-5. PubMed ID: 6312398 [TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone for once-a-day therapy of urinary tract infections. Childs SJ; Wells WG; Mirelman S Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]